Table 4.

Univariate relationships between AM and selected clinical outcomes

	GVH			HVG
Outcome	HR	95% CI	P	HR	95% CI	P
Class I AM*
Relapse	0.917	0.688-1.223	NS	1.042	0.788-1.377	NS
RFS	1.178	0.909-1.526	NS	1.363	1.056-1.760	.018
Neutrophil engraftment	—	—	—	0.870	0.743-1.019	.085
Platelet engraftment	—	—	—	0.871	0.743-1.021	.088
Class II AM†
Relapse	0.720	0.524-0.990	.043	0.785	0.571-1.079	.136
RFS	0.819	0.633-1.061	.130	0.922	0.715-1.188	NS
Neutrophil engraftment	—	—	—	0.876	0.684-1.120	NS
Platelet engraftment	—	—	—	0.734	0.575-0.938	.013
Total AM‡
Relapse	0.848	0.696-1.033	NS	0.914	0.749-1.116	NS
RFS	0.998	0.849-1.175	NS	1.131	0.948-1.349	.173
Neutrophil engraftment	—	—	—	0.896	0.786-1.022	.101
Platelet engraftment	—	—	—	0.832	0.738-0.937	.002

—, test not performed.

^*GVH (median, 3; range, 0-3); HVG (median, 3; range, 0-3).

^†GVH (median, 2; range, 0-2); HVG (median, 2; range, 0-2).

^‡GVH (median, 4; range, 0-5); HVG (median, 4; range, 0-5).